The effect of ACE inhibition (e.g., perindopril) in subjects with essential hypertension has been confirmed: after one month of therapy, there was a noticeable decrease in platelet aggregation induced by adrenaline, supporting the conclusion that ACE inhibitors enhance NO’s anti-aggregatory capacity in clinical populations [37]. This evidence concerns the gene ACE and essential hypertension.